The North America analgesics market size reached US$ 24.2 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 31.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2023-2032.
An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal anti-inflammatory drugs (NSAIDs), such as the salicylates, and opioid drugs, including morphine and oxycodone. Analgesics are taken to relieve pain that can arise from appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc.
The North America analgesics market is currently driven by several factors. The rising geriatric population suffering from incurable health issues, such as joint pain, has stimulated the demand for pain treatment therapies. These therapies employ different types of analgesics, thus catalyzing the market growth in the region. Moreover, the prevalence of osteoarthritis, cardiovascular diseases and cancer have substantially risen in the region, which has also induced the demand for analgesics. Furthermore, the growing number of surgeries, coupled with the penetration of effective pain management medications is expected to fuel the growth of the market during the next few years. Apart from this, availability of analgesics drugs in forms of gels, creams, sprays and oral tablets has made them consumer friendly.
An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal anti-inflammatory drugs (NSAIDs), such as the salicylates, and opioid drugs, including morphine and oxycodone. Analgesics are taken to relieve pain that can arise from appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc.
The North America analgesics market is currently driven by several factors. The rising geriatric population suffering from incurable health issues, such as joint pain, has stimulated the demand for pain treatment therapies. These therapies employ different types of analgesics, thus catalyzing the market growth in the region. Moreover, the prevalence of osteoarthritis, cardiovascular diseases and cancer have substantially risen in the region, which has also induced the demand for analgesics. Furthermore, the growing number of surgeries, coupled with the penetration of effective pain management medications is expected to fuel the growth of the market during the next few years. Apart from this, availability of analgesics drugs in forms of gels, creams, sprays and oral tablets has made them consumer friendly.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the North America analgesics market report, along with forecasts at the regional and country level from 2024-2032. The report has categorized the market based on type, drug class, route of administration, pain type and application.- Key Regions Analysed
- United States
- Canada
- Mexico
- Analysis for Each Country
Market by Type
- Prescription Analgesics
- OTC Analgesics
Market by Drug Class
- Opioids
- NSAID
- Others
Market by Route of Administration
- Oral
- Parenteral
- Topical
- Transdermal
- Rectal
Market by Pain Type
- Musculoskeletal Pain
- Surgical and Trauma Pain
- Cancer Pain
- Neuropathic Pain
- Migraine
- Obstetrical Pain
- Fibromyalgia
- Pain due to Burns
- Dental/Facial Pain
- Pediatric Pain
- Others
Market by Application
- Internal Analgesics
External Analgesics
- Value Chain Analysis
- Key Drivers and Challenges
- Porters Five Forces Analysis
- PESTEL Analysis
- Government Regulations
- Competitive Landscape
- Competitive Structure
- Key Player Profiles
Key Questions Answered in This Report:
- How has the North America analgesics market performed so far and how will it perform in the coming years?
- What are the key regions in the North America analgesics market?
- What has been the impact of COVID-19 on the North America analgesics market?
- What is the breakup of the North America analgesics market on the basis of type?
- What is the breakup of the North America analgesics market on the basis of drug class?
- What is the breakup of the North America analgesics market on the basis of route of administration?
- What is the breakup of the North America analgesics market on the basis of pain type?
- What is the breakup of the North America analgesics market on the basis of application?
- What are the various stages in the value chain of the North America analgesics industry?
- What are the key driving factors and challenges in the North America analgesics industry?
- What is the structure of the North America analgesics industry and who are the key players?
- What is the degree of competition in the North America analgesics industry?
- What are the profit margins in the North America analgesics industry?
Table of Contents
1 Preface3 Executive Summary16 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Analgesics Market
6 North America Analgesics Market
7 North America Analgesics Market: Breakup by Type
8 North America Analgesics Market: Breakup by Drug Class
9 North America Analgesics Market: Breakup by Route of Administration
10 North America Analgesics Market: Breakup by Pain Type
11 North America Analgesics Market: Breakup by Application
12 North America Analgesics Market: Breakup by Country
13 SWOT Analysis
14 Value Chain Analysis
15 Porter’s Five Forces Analysis
17 Competitive Landscape
List of Figures
List of Tables
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 123 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 24.2 Billion |
| Forecasted Market Value ( USD | $ 31.9 Billion |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | North America |
